Grants for Biotech Companies in California (2026)
California is one of the world's leading biotech markets, with clusters in South San Francisco / Mission Bay, the Torrey Pines / La Jolla corridor in San Diego, and emerging activity in LA's Westside. For bootstrapped California biotech founders, non-dilutive capital primarily flows through federal NIH SBIR/STTR programs (the single largest non-dilutive life sciences funder in the world), BARDA, CDMRP, and NSF. California-specific programs include CIRM (California Institute for Regenerative Medicine), which funds stem cell and regenerative medicine research with substantial awards — one of the largest state-level biotech grant programs in the U.S. The University of California technology commercialization offices fund spin-outs from UC research. Biocom California supports SBIR/STTR application development. Private programs include Y Combinator Bio, IndieBio (SOSV), and foundation-funded disease-specific research grants (ALS Association, Parker Institute for Cancer Immunotherapy). Bootstrap Directory aggregates California biotech grants across federal, state, and private sources for efficient prioritization. California biotech teams stacking NIH SBIR Phase I and II with CIRM awards can routinely build 24-36 months of non-dilutive runway pre-Series A.
Last updated
This guide and matching listings are refreshed from the Bootstrap Directory database as source data changes.
Data sources
Sources include Grants.gov, SAM.gov, SBIR.gov, CareerOneStop, state agencies, universities, and verified organizations.
Refresh cadence
Listings are checked weekly where source data allows, with stale or closed programs removed from public results.
Verification
Always confirm eligibility, deadlines, and award details on the official source or application page before applying.
Get alerts for this search
Create a free account, run the matching search, and save it to get new funding, grant, or training updates.
Featured Opportunities
NIH REACH — Research Evaluation and Commercialization Hubs
DoW Neurofibromatosis Synergistic Idea Award
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
DoW Rare Cancers Concept Award
Engineering Biological and Biomedical Systems (EBBS)
DoW Ovarian Cancer, Clinical Trial Award
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats
Frequently Asked Questions
What is CIRM?
CIRM is the California Institute for Regenerative Medicine, a state-funded biomedical research agency that supports stem cell and regenerative medicine research in California. It has awarded billions in funding over its history through discovery, translational, and clinical grant programs. CIRM eligibility is California-focused and typically requires California research operations.
How does IndieBio work?
IndieBio is a biotech-focused accelerator (part of SOSV) with a cohort model that includes equity investment alongside lab space, mentorship, and structured program support. Based in San Francisco with a sister program in NYC. Not strictly non-dilutive, but the investment is relatively small and the lab/mentor stack is unusual for biotech founders.
When are California biotech grant deadlines?
NIH SBIR solicitations open 3x annually (January, April, September typically). CIRM has specific RFAs with their own cycles. BARDA, CDMRP run on agency-specific windows. IndieBio has two cohorts annually. Bootstrap Directory tracks current California biotech openings across all programs.